DMK: DMK Pharmaceuticals regains full rights to commercialize Zimhi (naloxone)
DMK Pharmaceuticals Corporation announces that it has regained the full rights to commercialize Zimhi (naloxone) after the termination of an exclusive commercialization and distribution with US World Meds, LLC
Read full article »
Adamis Pharmaceuticals is a California-based biotechnology company that discovers and develops novel therapeutics for the treatment of neuro-based disorders.
Read more